Not applicableStudy completedNCT05885373What this trial is testingA Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLDWho this might be right forNon-Alcoholic Fatty Liver Disease GenieBiome Limited 40
Post-approval studies (Phase 4)Study completedNCT04038853What this trial is testingVitamin D in Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver DiseaseVitamin D Deficiency University Hospital Rijeka 360
Not applicableActive Not RecruitingNCT07514377What this trial is testingJiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in ChinaWho this might be right forEnvironmental ExposureFertilityHealth Problems in Pregnancy+7 more National Research Institute for Family Planning, China 100,000
Testing effectiveness (Phase 2)Study completedNCT03976401What this trial is testingEfruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)Who this might be right forNASH - Nonalcoholic Steatohepatitis Akero Therapeutics, Inc 110
Not applicableUnknownNCT04482153What this trial is testingPrevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University HospitalsWho this might be right forStudy of the NAFLD in CKD Patients Using Fibroscan Study Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT02413372What this trial is testingBMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)Who this might be right forNon-Alcoholic Steatohepatitis Bristol-Myers Squibb 184
Not applicableStudy completedNCT07338331What this trial is testingComparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver DiseaseWho this might be right forDiabete Type 2Non Alcoholic Fatty Liver Galala University 80
Testing effectiveness (Phase 2)Study completedNCT03008070What this trial is testingPhase 2b Study in NASH to Assess IVA337Who this might be right forNon-Alcoholic Steatohepatitis (NASH) Inventiva Pharma 247
Not applicableStudy completedNCT05224037What this trial is testingComparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouchWho this might be right forChronic Liver DiseaseLiver FibrosisLiver Steatoses Federal State Budgetary Scientific Institution 100
Early research (Phase 1)Ended earlyNCT06007651What this trial is testingLY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)Who this might be right forDyslipidemiasNon-Alcoholic Fatty Liver Disease Eli Lilly and Company 49
Not applicableUnknownNCT05447351What this trial is testingBeneficial Effects of Dietary and Lifestyle Change in Overweight and Obese SubjectsWho this might be right forOverweight and ObesityCardiovascular DiseasesMetabolic Syndrome+1 more University of Bari 200
Not applicableStudy completedNCT03250572What this trial is testingSerum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD PatientsWho this might be right forNon-Alcoholic Fatty Liver Disease Ain Shams University 113
Not applicableWithdrawnNCT01279434What this trial is testingVitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical TrialWho this might be right forNon Alcoholic Steatohepatitis Institute of Liver and Biliary Sciences, India
Not applicableLooking for participantsNCT05165706What this trial is testingLongitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceWho this might be right forDiabetes Mellitus, Type 2PreDiabetesInsulin Resistance+4 more Stanford University 110
Not applicableStudy completedNCT00968747What this trial is testingRegulation of FGF21 by Nutritional ChallengesWho this might be right forFastingNon-alcoholic Fatty Liver Disease (NAFLD) Beth Israel Deaconess Medical Center 40
Not applicableStudy completedNCT01894438What this trial is testingMediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH) Harokopio University 63
Post-approval studies (Phase 4)UnknownNCT02964715What this trial is testingThe Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 DiabetesWho this might be right forType2 DiabetesNAFLD University of Malaya 25
Not applicableStudy completedNCT04791397What this trial is testingEvaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.Who this might be right forVascular StiffnessLiver FibrosesMetabolic Syndrome+2 more I.M. Sechenov First Moscow State Medical University 62
Testing effectiveness (Phase 2)Ended earlyNCT02029586What this trial is testingTherapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except CirrhosisWho this might be right forNonalcoholic Fatty Liver Disease Yungjin Pharm. Co., Ltd. 18
Post-approval studies (Phase 4)UnknownNCT02213224What this trial is testingPerindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty Liver Disease (NAFLD) Nanfang Hospital, Southern Medical University 180